Form
20-F þ
|
Form
40-F o
|
Yes
o
|
No
þ
|
EXFO
ELECTRO-OPTICAL ENGINEERING INC.
|
|
By:
/s/ Germain
Lamonde
Name:
Germain Lamonde
Title:
President and Chief Executive Officer
|
|
§
|
Sales
increase 22.9% year-over-year to US$43.3 million (slightly above
guidance)
|
§
|
Net
bookings improve 22.0% to record-high of US$44.5 million (book-to-bill
ratio of 1.03)
|
§
|
Gross
margin reaches 58.3%, highest level since Q4
2001
|
§
|
Nine
products launched (new products accounted for 44.4% of total
sales)
|
§
|
Acquisition
of Navtel Communications, IMS and VoIP test supplier to
NEMs
|
Segmented
results:
|
Q2 2008 | Q1 2008 | Q2 2007 | |||||||||
(unaudited)
|
(unaudited)
|
(unaudited)
|
||||||||||
Sales:
|
||||||||||||
Telecom
Division
|
$ | 37,435 | $ | 35,365 | $ | 29,297 | ||||||
Life
Sciences and Industrial Division
|
5,846 | 5,620 | 5,910 | |||||||||
Total
|
$ | 43,281 | $ | 40,985 | $ | 35,207 | ||||||
Earnings
from operations:
|
||||||||||||
Telecom
Division
|
$ | 2,817 | $ | 21 | $ | 1,078 | ||||||
Life
Sciences and Industrial Division
|
818 | 281 | 1003 | |||||||||
Total
|
$ | 3,635 | $ | 302 | $ | 2,081 | ||||||
Other
selected information:
|
||||||||||||
GAAP
net earnings (loss)
|
$ | 4,024 | $ | (93 | ) | $ | 2,684 | |||||
After-tax
amortization of intangible assets
|
$ | 490 | $ | 499 | $ | 630 | ||||||
Stock-based
compensation costs
|
$ | 269 | $ | 301 | $ | 241 | ||||||
Future
income tax recovery
|
$ | (2,715 | ) | $ | – | $ | – | |||||
Effect
of changes in Canadian tax rates
|
$ | 1,524 | $ | – | $ | – |
As
at
February
29,
2008
|
As
at
August
31,
2007
|
|||||||
(unaudited)
|
||||||||
Assets
|
||||||||
Current
assets
|
||||||||
Cash
|
$ | 9,211 | $ | 5,541 | ||||
Short-term
investments (note 2)
|
133,549 | 124,217 | ||||||
Accounts
receivable
|
||||||||
Trade,
less allowance for doubtful accounts of $224
($206
as at August 31, 2007)
|
29,017 | 26,699 | ||||||
Other
(note 2)
|
5,129 | 2,479 | ||||||
Income
taxes and tax credits recoverable
|
2,778 | 6,310 | ||||||
Inventories
(note 3)
|
33,276 | 31,513 | ||||||
Prepaid
expenses
|
1,884 | 1,391 | ||||||
Future
income taxes
|
11,256 | 7,609 | ||||||
226,100 | 205,759 | |||||||
Other
receivable
|
805 | − | ||||||
Tax
credits recoverable
|
14,224 | − | ||||||
Property,
plant and equipment
|
20,563 | 18,117 | ||||||
Intangible
assets
|
9,341 | 9,628 | ||||||
Goodwill
|
30,546 | 28,437 | ||||||
Future
income taxes
|
4,180 | 17,197 | ||||||
$ | 305,759 | $ | 279,138 | |||||
Liabilities
|
||||||||
Current
liabilities
|
||||||||
Bank
loan
|
$ | 703 | $ | − | ||||
Accounts
payable and accrued liabilities (note 4)
|
21,010 | 22,721 | ||||||
Income
taxes payable
|
368 | − | ||||||
Deferred
revenue
|
3,126 | 2,598 | ||||||
25,207 | 25,319 | |||||||
Deferred
revenue
|
3,841 | 3,414 | ||||||
Future
income taxes
|
− | 240 | ||||||
29,048 | 28,973 | |||||||
Contingency (note
5)
|
||||||||
Shareholders’
Equity
|
||||||||
Share
capital (note 6)
|
150,105 | 150,019 | ||||||
Contributed
surplus
|
4,827 | 4,453 | ||||||
Retained
earnings
|
46,222 | 42,275 | ||||||
Accumulated
other comprehensive income (note 2)
|
75,557 | 53,418 | ||||||
276,711 | 250,165 | |||||||
$ | 305,759 | $ | 279,138 |
Three
months ended
February
29, 2008
|
Six
months ended
February
29, 2008
|
Three
months ended
February
28, 2007
|
Six
months ended
February
28, 2007
|
|||||||||||||
Sales
|
$ | 43,281 | $ | 84,266 | $ | 35,207 | $ | 70,754 | ||||||||
Cost of sales (1,2)
|
18,060 | 36,204 | 14,970 | 30,199 | ||||||||||||
Gross
margin
|
25,221 | 48,062 | 20,237 | 40,555 | ||||||||||||
Operating
expenses
|
||||||||||||||||
Selling
and administrative (1)
|
13,683 | 28,500 | 12,184 | 23,726 | ||||||||||||
Net
research and development (1)
(note 7)
|
6,185 | 12,197 | 4,678 | 9,032 | ||||||||||||
Amortization
of property, plant and equipment
|
998 | 1,974 | 664 | 1,445 | ||||||||||||
Amortization
of intangible assets
|
720 | 1,454 | 630 | 1,512 | ||||||||||||
Total
operating expenses
|
21,586 | 44,125 | 18,156 | 35,715 | ||||||||||||
Earnings
from operations
|
3,635 | 3,937 | 2,081 | 4,840 | ||||||||||||
Interest income
|
1,616 | 3,099 | 1,105 | 2,277 | ||||||||||||
Foreign
exchange gain (loss)
|
(232 | ) | (848 | ) | 352 | 735 | ||||||||||
Earnings
before income taxes
|
5,019 | 6,188 | 3,538 | 7,852 | ||||||||||||
Income taxes (note
8)
|
||||||||||||||||
Current
|
(8,373 | ) | (7,192 | ) | 854 | 1,635 | ||||||||||
Future
|
9,368 | 9,449 | – | – | ||||||||||||
995 | 2,257 | 854 | 1,635 | |||||||||||||
Net
earnings for the period
|
$ | 4,024 | $ | 3,931 | $ | 2,684 | $ | 6,217 | ||||||||
Basic
and diluted net earnings per share
|
$ | 0.06 | $ | 0.06 | $ | 0.04 | $ | 0.09 | ||||||||
Basic
weighted average number of shares outstanding (000’s)
|
68,984 | 68,992 | 68,839 | 68,807 | ||||||||||||
Diluted weighted average number
of shares outstanding (000’s) (note 9)
|
69,490 | 69,582 | 69,546 | 69,465 | ||||||||||||
(1)
Stock-based compensation
costs included in:
|
||||||||||||||||
Cost
of sales
|
$ | 38 | $ | 75 | $ | 27 | $ | 61 | ||||||||
Selling
and administrative
|
183 | 380 | 159 | 356 | ||||||||||||
Net
research and development
|
48 | 115 | 55 | 109 | ||||||||||||
$ | 269 | $ | 570 | $ | 241 | $ | 526 |
(2)
|
The
cost of sales is exclusive of amortization, shown
separately.
|
Comprehensive
income (loss)
|
||||||||||||||||
Three
months ended
February
29, 2008
|
Six
months ended
February
29, 2008
|
Three
months ended
February
28, 2007
|
Six
months ended
February
28, 2007
|
|||||||||||||
Net
earnings for the period
|
$ | 4,024 | $ | 3,931 | $ | 2,684 | $ | 6,217 | ||||||||
Foreign
currency translation adjustment
|
5,827 | 19,733 | (4,734 | ) | (10,760 | ) | ||||||||||
Changes
in unrealized losses on short-term investments
|
51 | 90 | – | – | ||||||||||||
Unrealized
gains on forward exchange contracts
|
600 | 2,549 | – | – | ||||||||||||
Reclassification
of realized gains on forward exchange contracts in net
earnings
|
(1,168 | ) | (1,927 | ) | – | – | ||||||||||
Future
income taxes effect of the above items
|
182 | (199 | ) | – | – | |||||||||||
Comprehensive
income (loss)
|
$ | 9,516 | $ | 24,177 | $ | (2,050 | ) | $ | (4,543 | ) |
Accumulated
other comprehensive income
|
||||||||
Six
months ended
February
29, 2008
|
Six
months ended
February
28, 2007
|
|||||||
Foreign
currency translation adjustment
|
||||||||
Cumulative
effect of prior periods
|
$ | 53,418 | $ | 43,537 | ||||
Current
period
|
19,733 | (10,760 | ) | |||||
73,151 | 32,777 | |||||||
Unrealized
gains on forward exchange contracts
|
||||||||
Adjustment
related to the implementation of new accounting standards (note
2)
|
1,948 | − | ||||||
Current
period, net of realized gains and future income taxes
|
423 | − | ||||||
2,371 | − | |||||||
Unrealized
losses on short-term investments
|
||||||||
Adjustment
related to the implementation of new accounting standards (note
2)
|
(55 | ) | − | |||||
Current
period, net of future income taxes
|
90 | − | ||||||
35 | − | |||||||
Accumulated
other comprehensive income
|
$ | 75,557 | $ | 32,777 |
Retained
earnings
|
||||||||
Six
months
ended
February
29, 2008
|
Six
months
ended
February
28, 2007
|
|||||||
Balance
– Beginning of the period
|
$ | 42,275 | $ | − | ||||
Add
(deduct)
|
||||||||
Adjustment
related to the implementation of new accounting standards (note
2)
|
55 | − | ||||||
Net
earnings for the period
|
3,931 | 6,217 | ||||||
Premium
on redemption of share capital (note 6)
|
(39 | ) | − | |||||
Balance
– End of the period
|
$ | 46,222 | $ | 6,217 |
Contributed
surplus
|
||||||||
Six
months
ended
February
29, 2008
|
Six
months
ended
February
28, 2007
|
|||||||
Balance
– Beginning of the period
|
$ | 4,453 | $ | 3,776 | ||||
Add
(deduct)
|
||||||||
Stock-based
compensation costs
|
585 | 499 | ||||||
Reclassification
of stock-based compensation costs to share capital upon exercise of stock
awards
|
(211 | ) | (174 | ) | ||||
Balance
– End of the period
|
$ | 4,827 | $ | 4,101 |
Three
months ended
February
29, 2008
|
Six
months ended
February
29, 2008
|
Three
months ended
February
28, 2007
|
Six
months ended
February
28, 2007
|
|||||||||||||
Cash
flows from operating activities
|
||||||||||||||||
Net
earnings for the period
|
$ | 4,024 | $ | 3,931 | $ | 2,684 | $ | 6,217 | ||||||||
Add
(deduct) items not affecting cash
|
||||||||||||||||
Discount
on short-term investments
|
86 | 988 | 364 | 778 | ||||||||||||
Stock-based
compensation costs
|
269 | 570 | 241 | 526 | ||||||||||||
Amortization
|
1,718 | 3,428 | 1,294 | 2,957 | ||||||||||||
Deferred
revenue
|
151 | 502 | 745 | 1,239 | ||||||||||||
Government
grants
|
− | − | − | (22 | ) | |||||||||||
Future
income taxes
|
9,368 | 9,449 | − | − | ||||||||||||
15,616 | 18,868 | 5,328 | 11,695 | |||||||||||||
Change
in non-cash operating items
|
||||||||||||||||
Accounts
receivable
|
(985 | ) | 181 | (210 | ) | (3,245 | ) | |||||||||
Income
taxes and tax credits
|
(9,190 | ) | (9,648 | ) | (513 | ) | (931 | ) | ||||||||
Inventories
|
794 | 707 | (510 | ) | (129 | ) | ||||||||||
Prepaid
expenses
|
216 | (396 | ) | 133 | 135 | |||||||||||
Accounts
payable and accrued liabilities
|
2,735 | (2,959 | ) | 2,736 | 2,772 | |||||||||||
9,186 | 6,753 | 6,964 | 10,297 | |||||||||||||
Cash
flows from investing activities
|
||||||||||||||||
Additions
to short-term investments
|
(197,607 | ) | (409,060 | ) | (296,237 | ) | (490,503 | ) | ||||||||
Proceeds
from disposal and maturity of short-term
investments
|
194,009 | 408,580 | 291,413 | 482,916 | ||||||||||||
Additions
to capital assets (1)
|
(2,113 | ) | (3,686 | ) | (835 | ) | (1,646 | ) | ||||||||
Net
proceeds from disposal of capital assets
|
− | − | − | 1,228 | ||||||||||||
(5,711 | ) | (4,166 | ) | (5,659 | ) | (8,005 | ) | |||||||||
Cash
flows from financing activities
|
||||||||||||||||
Changes
in bank loan
|
− | 699 | − | − | ||||||||||||
Repayment
of long-term debt
|
− | − | (24 | ) | (51 | ) | ||||||||||
Redemption
of share capital (note 6)
|
− | (174 | ) | − | − | |||||||||||
Exercise
of stock options
|
10 | 10 | 362 | 483 | ||||||||||||
10 | 535 | 338 | 432 | |||||||||||||
Effect
of foreign exchange rate changes on cash
|
205 | 548 | (276 | ) | (469 | ) | ||||||||||
Change
in cash
|
3,690 | 3,670 | 1,367 | 2,255 | ||||||||||||
Cash
– Beginning of period
|
5,521 | 5,541 | 7,741 | 6,853 | ||||||||||||
Cash
– End of period
|
$ | 9,211 | $ | 9,211 | $ | 9,108 | $ | 9,108 |
1.
|
Interim
financial information
|
2.
|
New
accounting standards and
pronouncements
|
3.
|
Inventories
|
As
at
February
29,
2008
|
As
at
August
31,
2007
|
|||||||
(unaudited)
|
||||||||
Raw
materials
|
$ | 16,513 | $ | 16,898 | ||||
Work
in progress
|
2,186 | 1,387 | ||||||
Finished
goods
|
14,577 | 13,228 | ||||||
$ | 33,276 | $ | 31,513 |
4.
|
Accounts
payable and accrued liabilities
|
As
at
February
29,
2008
|
As
at
August
31,
2007
|
|||||||
(unaudited)
|
||||||||
Trade
|
$ | 8,877 | $ | 11,749 | ||||
Salaries
and social benefits
|
8,406 | 7,929 | ||||||
Warranty
|
840 | 800 | ||||||
Commissions
|
788 | 824 | ||||||
Other
|
2,099 | 1,419 | ||||||
$ | 21,010 | $ | 22,721 |
Six
months
ended
February
29,
2008
|
Six
months
ended
February
28,
2007
|
|||||||
(unaudited)
|
||||||||
Balance – Beginning of the
period
|
$ | 800 | $ | 1,006 | ||||
Provision
|
297 | 408 | ||||||
Settlements
|
(257 | ) | (625 | ) | ||||
Balance – End of the
period
|
$ | 840 | $ | 789 |
5.
|
Contingency
|
6.
|
Share
capital
|
|
The
following tables summarize changes in share capital for the six months
ended February 28, 2007, and
February 29, 2008:
|
Six
months ended February 28, 2007
|
||||||||||||||||||||
Multiple
voting shares
|
Subordinate
voting shares
|
|||||||||||||||||||
Number
|
Amount
|
Number
|
Amount
|
Total
amount
|
||||||||||||||||
(unaudited)
|
||||||||||||||||||||
Balance
as at August 31, 2006
|
37,143,000 | $ | 1 | 31,609,969 | $ | 148,920 | $ | 148,921 | ||||||||||||
Exercise
of stock options
|
– | – | 41,550 | 121 | 121 | |||||||||||||||
Redemption
of restricted share units
|
– | – | 88 | – | – | |||||||||||||||
Reclassification
of stock-based compensation costs to share capital upon exercise of stock
awards
|
– | – | – | 47 | 47 | |||||||||||||||
Balance
as at November 30, 2006
|
37,143,000 | 1 | 31,651,607 | 149,088 | 149,089 | |||||||||||||||
Exercise
of stock options
|
– | – | 109,723 | 362 | 362 | |||||||||||||||
Redemption
of restricted share units
|
– | – | 976 | – | – | |||||||||||||||
Reclassification
of stock-based compensation costs to share capital upon exercise of stock
awards
|
– | – | – | 127 | 127 | |||||||||||||||
Balance
as at February 28, 2007
|
37,143,000 | $ | 1 | 31,762,306 | $ | 149,577 | $ | 149,578 |
Six
months ended February 29, 2008
|
||||||||||||||||||||
Multiple
voting shares
|
Subordinate
voting shares
|
|||||||||||||||||||
Number
|
Amount
|
Number
|
Amount
|
Total
amount
|
||||||||||||||||
(unaudited)
|
||||||||||||||||||||
Balance
as at August 31, 2007
|
36,643,000 | $ | 1 | 32,361,561 | $ | 150,018 | $ | 150,019 | ||||||||||||
Reclassification
of stock-based compensation costs to share capital upon exercise of stock
awards
|
– | – | – | 2 | 2 | |||||||||||||||
Redemption
of share capital
|
– | – | (29,200 | ) | (135 | ) | (135 | ) | ||||||||||||
Balance
as at November 30, 2007
|
36,643,000 | 1 | 32,332,361 | 149,885 | 149,886 | |||||||||||||||
Exercise
of stock options
|
– | – | 4,000 | 10 | 10 | |||||||||||||||
Redemption
of restricted share units
|
– | – | 38,031 | – | – | |||||||||||||||
Reclassification
of stock-based compensation costs to share capital upon exercise of stock
awards
|
– | – | – | 209 | 209 | |||||||||||||||
Balance
as at February 29, 2008
|
36,643,000 | $ | 1 | 32,374,392 | $ | 150,104 | $ | 150,105 |
7.
|
Net
research and development expenses
|
Three
months ended
February
29, 2008
|
Six
months ended
February
29, 2008
|
Three
months ended
February
28, 2007
|
Six
months ended
February
28, 2007
|
|||||||||||||
(unaudited)
|
(unaudited)
|
|||||||||||||||
Gross
research and development expenses
|
$ | 7,575 | $ | 15,061 | $ | 5,939 | $ | 11,448 | ||||||||
Research
and development tax credits and grants
|
(1,390 | ) | (2,864 | ) | (1,261 | ) | (2,416 | ) | ||||||||
$ | 6,185 | $ | 12,197 | $ | 4,678 | $ | 9,032 |
8.
|
Income
taxes
|
Three
months ended
February
29,
2008
|
Six
months ended
February
29,
2008
|
Three
months ended
February
28,
2007
|
Six
months ended
February
28,
2007
|
|||||||||||||
(unaudited)
|
(unaudited)
|
|||||||||||||||
Income
tax provision at combined Canadian federal and provincial statutory tax
rate
|
$ | 1,606 | $ | 1,980 | $ | 1,132 | $ | 2,512 | ||||||||
Increase
(decrease) due to:
|
||||||||||||||||
Income
taxed at different rates
|
(11 | ) | 77 | (26 | ) | 33 | ||||||||||
Non-taxable
income
|
(290 | ) | (371 | ) | (36 | ) | (95 | ) | ||||||||
Non-deductible
expenses
|
368 | 590 | 192 | 446 | ||||||||||||
Change
in tax rates (1)
|
1,524 | 1,522 | 18 | 289 | ||||||||||||
Change
in tax strategy (2)
|
(2,715 | ) | (2,715 | ) | – | – | ||||||||||
Foreign
exchange effect of translation of foreign integrated
subsidiaries
|
67 | 194 | 6 | 86 | ||||||||||||
Other
|
232 | 391 | 163 | 40 | ||||||||||||
Utilization
of previously unrecognized future income tax assets
|
(1,881 | ) | (1,881 | ) | (660 | ) | (1,999 | ) | ||||||||
Unrecognized
future income tax assets on temporary deductible differences and unused
tax losses and deductions
|
2,095 | 2,470 | 65 | 323 | ||||||||||||
$ | 995 | $ | 2,257 | $ | 854 | $ | 1,635 |
Current
|
$ | (8,373 | ) | $ | (7,192 | ) | $ | 854 | $ | 1,635 | ||||||
Future
|
9,154 | 8,860 | 595 | 1,676 | ||||||||||||
Valuation
allowance
|
214 | 589 | (595 | ) | (1,676 | ) | ||||||||||
9,368 | 9,449 | – | – | |||||||||||||
$ | 995 | $ | 2,257 | $ | 854 | $ | 1,635 |
(1)
|
During
the three months ended February 29, 2008, reductions to the Canadian
federal statutory tax rate, previously announced by the Canadian federal
Government, were enacted. Therefore, Canadian federal future income tax
assets decreased by
$1,524,000, and generated a future income
tax expense for the same amount during the three-
and six-month periods ended
February 29, 2008.
|
(2)
|
During
the three months ended February 29, 2008, based on new Canadian federal
enacted tax rates, the company reviewed its tax strategy for the future
use of its Canadian federal operating losses, research and development
expenses, certain timing differences and research and development tax
credits to minimize income taxes payable on future years’ taxable income,
by amending its prior year’s income tax returns to generate a net
operating loss to be carried back to prior years, which will release
previously used research and development tax credits. This resulted in an
increase of its tax related assets of $2,715,000 and in an income tax
recovery for the same amount in the statements of earnings for the three-
and six-month periods ended
February 29, 2008.
|
9.
|
Earnings
per share
|
Three
months ended
February
29,
2008
|
Six
months
ended
February
29,
2008
|
Three
months ended
February
28,
2007
|
Six
months
ended
February
28,
2007
|
|||||||||||||
(unaudited)
|
(unaudited)
|
|||||||||||||||
Basic
weighted average number of shares outstanding (000’s)
|
68,984 | 68,992 | 68,839 | 68,807 | ||||||||||||
Plus
dilutive effect of:
|
||||||||||||||||
Stock
options (000’s)
|
241 | 321 | 468 | 451 | ||||||||||||
Restricted
share units (000’s)
|
188 | 195 | 190 | 161 | ||||||||||||
Deferred
share units (000’s)
|
77 | 74 | 49 | 46 | ||||||||||||
Diluted
weighted average number of shares outstanding (000’s)
|
69,490 | 69,582 | 69,546 | 69,465 | ||||||||||||
Stock
awards excluded from the calculation of diluted weighted average number of
shares because their exercise price was greater than the average market
price of the common shares (000’s)
|
1,697 | 1,415 | 1,213 | 1,299 |
10.
|
Segment
information
|
Three
months ended February 29, 2008
|
Six
months ended February 29, 2008
|
|||||||||||||||||||||||
Telecom
Division
|
Life
Sciences and Industrial Division
|
Total
|
Telecom
Division
|
Life
Sciences and Industrial Division
|
Total
|
|||||||||||||||||||
(unaudited)
|
(unaudited)
|
|||||||||||||||||||||||
Sales
|
$ | 37,435 | $ | 5,846 | $ | 43,281 | $ | 72,800 | $ | 11,466 | $ | 84,266 | ||||||||||||
Earnings
from operations
|
$ | 2,817 | $ | 818 | $ | 3,635 | $ | 2,838 | $ | 1,099 | $ | 3,937 | ||||||||||||
Unallocated
items:
|
||||||||||||||||||||||||
Interest
income
|
1,616 | 3,099 | ||||||||||||||||||||||
Foreign
exchange loss
|
(232 | ) | (848 | ) | ||||||||||||||||||||
Earnings
before income taxes
|
5,019 | 6,188 | ||||||||||||||||||||||
Income
taxes
|
995 | 2,257 | ||||||||||||||||||||||
Net
earnings for the period
|
$ | 4,024 | $ | 3,931 |
Three
months ended February 28, 2007
|
Six
months ended February 28, 2007
|
|||||||||||||||||||||||
Telecom
Division
|
Life
Sciences and Industrial Division
|
Total
|
Telecom
Division
|
Life
Sciences and Industrial Division
|
Total
|
|||||||||||||||||||
(unaudited)
|
(unaudited)
|
|||||||||||||||||||||||
Sales
|
$ | 29,297 | $ | 5,910 | $ | 35,207 | $ | 58,819 | $ | 11,935 | $ | 70,754 | ||||||||||||
Earnings
from operations
|
$ | 1,078 | $ | 1,003 | $ | 2,081 | $ | 2,881 | $ | 1,959 | $ | 4,840 | ||||||||||||
Unallocated
items:
|
||||||||||||||||||||||||
Interest
income
|
1,105 | 2,277 | ||||||||||||||||||||||
Foreign
exchange gain
|
352 | 735 | ||||||||||||||||||||||
Earnings
before income taxes
|
3,538 | 7,852 | ||||||||||||||||||||||
Income
taxes
|
854 | 1,635 | ||||||||||||||||||||||
Net
earnings for the period
|
$ | 2,684 | $ | 6,217 |
As
at
February
29,
2008
|
As
at
August
31,
2007
|
|||||||
(unaudited)
|
||||||||
Total
assets
|
||||||||
Telecom
Division
|
$ | 116,528 | $ | 109,065 | ||||
Life
Sciences and Industrial Division
|
10,324 | 9,199 | ||||||
Unallocated
assets
|
178,907 | 160,874 | ||||||
$ | 305,759 | $ | 279,138 |
11.
|
Differences
between Canadian and U.S. GAAP
|
Three
months ended
February
29,
2008
|
Six
months ended
February
29,
2008
|
Three
months ended
February
28,
2007
|
Six
months ended
February
28,
2007
|
|||||||||||||
(unaudited)
|
(unaudited)
|
|||||||||||||||
Net
earnings for the period in accordance with Canadian GAAP and U.S.
GAAP
|
$ | 4,024 | $ | 3,931 | $ | 2,684 | $ | 6,217 | ||||||||
Foreign
currency translation adjustment
|
5,540 | 18,722 | (4,472 | ) | (10,304 | ) | ||||||||||
Changes
in unrealized losses on available-for-sale securities
|
51 | 90 | – | – | ||||||||||||
Unrealized
gains (losses) on forward exchange contracts
|
600 | 2,549 | (3,718 | ) | (5,793 | ) | ||||||||||
Reclassification
of realized gains on forward exchange contracts in net
earnings
|
(1,168 | ) | (1,927 | ) | (108 | ) | (844 | ) | ||||||||
Future
income taxes effect of the above items
|
182 | (199 | ) | – | – | |||||||||||
Comprehensive
income (loss) under U.S. GAAP
|
$ | 9,229 | $ | 23,166 | $ | (5,614 | ) | $ | (10,724 | ) |
As
at
February
29,
2008
|
As
at
August
31,
2007
|
|||||||
(unaudited)
|
||||||||
Shareholders’
equity in accordance with Canadian GAAP
|
$ | 276,711 | $ | 250,165 | ||||
Forward
exchange contracts (note 2)
|
– | 2,864 | ||||||
Goodwill
|
(13,708 | ) | (12,697 | ) | ||||
Future
income tax assets (note 2)
|
– | (916 | ) | |||||
Stock
appreciation rights
|
(73 | ) | (73 | ) | ||||
Shareholders’
equity in accordance with U.S. GAAP
|
$ | 262,930 | $ | 239,343 |
Share
capital
|
Contributed
surplus
|
Deficit
|
Other
capital
|
Accumulated
other comprehensive income
|
Shareholders’
equity
|
|||||||||||||||||||
(unaudited)
|
||||||||||||||||||||||||
Balance
as at August 31, 2007
|
$ | 599,519 | $ | 1,537 | $ | (416,687 | ) | $ | 4,684 | $ | 50,290 | $ | 239,343 | |||||||||||
Net
loss for the period
|
– | – | (93 | ) | – | – | (93 | ) | ||||||||||||||||
Stock-based
compensation costs
|
– | – | – | 316 | – | 316 | ||||||||||||||||||
Foreign
currency translation adjustment
|
– | – | – | – | 13,182 | 13,182 | ||||||||||||||||||
Unrealized
losses on available-for-sale securities
|
– | – | – | – | 39 | 39 | ||||||||||||||||||
Unrealized
gains on forward exchange contracts, net of realized gains and future
income taxes
|
– | – | – | – | 809 | 809 | ||||||||||||||||||
Reclassification
of stock-based compensation costs upon exercise of stock
awards
|
2 | – | – | (2 | ) | – | – | |||||||||||||||||
Redemption
of share capital
|
(135 | ) | – | (39 | ) | – | – | (174 | ) | |||||||||||||||
Balance
as at November 30, 2007
|
599,386 | 1,537 | (416,819 | ) | 4,998 | 64,320 | 253,422 | |||||||||||||||||
Net
earnings for the period
|
– | – | 4,024 | – | – | 4,024 | ||||||||||||||||||
Stock-based
compensation costs
|
– | – | – | 269 | – | 269 | ||||||||||||||||||
Foreign
currency translation adjustment
|
– | – | – | – | 5,540 | 5,540 | ||||||||||||||||||
Unrealized
losses on available-for-sale securities
|
– | – | – | – | 51 | 51 | ||||||||||||||||||
Unrealized
gains on forward exchange contracts, net of realized gains and future
income taxes
|
– | – | – | – | (386 | ) | (386 | ) | ||||||||||||||||
Exercise
of stock options
|
10 | – | – | – | – | 10 | ||||||||||||||||||
Reclassification
of stock-based compensation costs upon exercise of stock
awards
|
209 | – | – | (209 | ) | – | – | |||||||||||||||||
Balance
as at February 29, 2008
|
$ | 599,605 | $ | 1,537 | $ | (412,795 | ) | $ | 5,058 | $ | 69,525 | $ | 262,930 |
As
at
February
29,
2008
|
As
at
August
31,
2007
|
|||||||
(unaudited)
|
||||||||
Foreign
currency translation adjustment
|
||||||||
Current
period
|
$ | 18,722 | $ | 9,218 | ||||
Cumulative
effect of prior periods
|
48,397 | 39,179 | ||||||
67,119 | 48,397 | |||||||
Unrealized
gains (losses) on forward exchange contracts
|
||||||||
Current
period, net of realized gains (losses) and future income
taxes
|
423 | (3,503 | ) | |||||
Cumulative
effect of prior periods, net of future income taxes
|
1,948 | 5,451 | ||||||
2,371 | 1,948 | |||||||
Unrealized
losses on available-for-sale securities
|
||||||||
Current
period, net of future incomes taxes
|
90 | (55 | ) | |||||
Cumulative
effect of prior periods, net of future income taxes
|
(55 | ) | − | |||||
35 | (55 | ) | ||||||
$ | 69,525 | $ | 50,290 |
12.
|
Subsequent
events
|
Three
months
ended
February
29,
2008
|
Three
months
ended
February
28,
2007
|
Six
months
ended
February
29,
2008
|
Six
months
ended
February
28,
2007
|
|||||||||||||
(unaudited)
|
(unaudited)
|
|||||||||||||||
Sales
|
$ | 43,281 | $ | 35,207 | $ | 84,266 | $ | 70,754 | ||||||||
Cost
of sales (1)
|
18,060 | 14,970 | 36,204 | 30,199 | ||||||||||||
Gross
margin
|
25,221 | 20,237 | 48,062 | 40,555 | ||||||||||||
Operating
expenses
|
||||||||||||||||
Selling
and administrative
|
13,683 | 12,184 | 28,500 | 23,726 | ||||||||||||
Net
research and development
|
6,185 | 4,678 | 12,197 | 9,032 | ||||||||||||
Amortization
of property, plant and equipment
|
998 | 664 | 1,974 | 1,445 | ||||||||||||
Amortization
of intangible assets
|
720 | 630 | 1,454 | 1,512 | ||||||||||||
Total
operating expenses
|
21,586 | 18,156 | 44,125 | 35,715 | ||||||||||||
Earnings
from operations
|
3,635 | 2,081 | 3,937 | 4,840 | ||||||||||||
Interest
income
|
1,616 | 1,105 | 3,099 | 2,277 | ||||||||||||
Foreign
exchange gain (loss)
|
(232 | ) | 352 | (848 | ) | 735 | ||||||||||
Earnings
before income taxes
|
5,019 | 3,538 | 6,188 | 7,852 | ||||||||||||
Income
taxes (2)
|
995 | 854 | 2,257 | 1,635 | ||||||||||||
Net
earnings for the period
|
$ | 4,024 | $ | 2,684 | $ | 3,931 | $ | 6,217 | ||||||||
Basic
and diluted net earnings per share
|
$ | 0.06 | $ | 0.04 | $ | 0.06 | $ | 0.09 | ||||||||
Segmented
information:
|
||||||||||||||||
Sales:
|
||||||||||||||||
Telecom
Division
|
$ | 37,435 | $ | 29,297 | $ | 72,800 | $ | 58,819 | ||||||||
Life
Sciences and Industrial Division
|
5,846 | 5,910 | 11,466 | 11,935 | ||||||||||||
$ | 43,281 | $ | 35,207 | $ | 84,266 | $ | 70,754 | |||||||||
Earnings
from operations:
|
||||||||||||||||
Telecom
Division
|
$ | 2,817 | $ | 1,078 | $ | 2,838 | $ | 2,881 | ||||||||
Life
Sciences and Industrial Division
|
818 | 1,003 | 1,099 | 1,959 | ||||||||||||
$ | 3,635 | $ | 2,081 | $ | 3,937 | $ | 4,840 | |||||||||
Research
and development data:
|
||||||||||||||||
Gross
research and development
|
$ | 7,575 | $ | 5,939 | $ | 15,061 | $ | 11,448 | ||||||||
Net
research and development
|
$ | 6,185 | $ | 4,678 | $ | 12,197 | $ | 9,032 |
(1)
|
The
cost of sales is exclusive of amortization, shown
separately.
|
(2)
|
Include
a one-time income tax expense of $1.5 million as a result of changes in
Canadian federal enacted tax rates and an income tax recovery of $2.7
million as a result of changes of our tax strategy, for the three and the
six months ended February 29,
2008.
|
Three
months
ended
February
29,
2008
|
Three
months
ended
February
28,
2007
|
Six
months
ended
February
29,
2008
|
Six
months
ended
February
28,
2007
|
|||||||||||||
(unaudited)
|
(unaudited)
|
|||||||||||||||
Sales
|
100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % | ||||||||
Cost
of sales (1)
|
41.7 | 42.5 | 43.0 | 42.7 | ||||||||||||
Gross
margin
|
58.3 | 57.5 | 57.0 | 57.3 | ||||||||||||
Operating
expenses
|
||||||||||||||||
Selling
and administrative
|
31.6 | 34.6 | 33.8 | 33.5 | ||||||||||||
Net
research and development
|
14.3 | 13.3 | 14.5 | 12.8 | ||||||||||||
Amortization
of property, plant and equipment
|
2.3 | 1.9 | 2.3 | 2.0 | ||||||||||||
Amortization
of intangible assets
|
1.7 | 1.8 | 1.7 | 2.2 | ||||||||||||
Total
operating expenses
|
49.9 | 51.6 | 52.3 | 50.5 | ||||||||||||
Earnings
from operations
|
8.4 | 5.9 | 4.7 | 6.8 | ||||||||||||
Interest
income
|
3.7 | 3.1 | 3.6 | 3.2 | ||||||||||||
Foreign
exchange gain (loss)
|
(0.5 | ) | 1.0 | (1.0 | ) | 1.1 | ||||||||||
Earnings
before income taxes
|
11.6 | 10.0 | 7.3 | 11.1 | ||||||||||||
Income
taxes (2)
|
2.3 | 2.4 | 2.6 | 2.3 | ||||||||||||
Net
earnings for the period
|
9.3 | % | 7.6 | % | 4.7 | % | 8.8 | % | ||||||||
Segmented
information:
|
||||||||||||||||
Sales:
|
||||||||||||||||
Telecom
Division
|
86.5 | % | 83.2 | % | 86.4 | % | 83.1 | % | ||||||||
Life
Sciences and Industrial Division
|
13.5 | 16.8 | 13.6 | 16.9 | ||||||||||||
100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % | |||||||||
Earnings
from operations:
|
||||||||||||||||
Telecom
Division
|
6.5 | % | 3.1 | % | 3.4 | % | 4.1 | % | ||||||||
Life
Sciences and Industrial Division
|
1.9 | 2.8 | 1.3 | 2.7 | ||||||||||||
8.4 | % | 5.9 | % | 4.7 | % | 6.8 | % | |||||||||
Research
and development data:
|
||||||||||||||||
Gross
research and development
|
17.5 | % | 16.9 | % | 17.9 | % | 16.2 | % | ||||||||
Net
research and development
|
14.3 | % | 13.3 | % | 14.5 | % | 12.8 | % |
(1)
|
The
cost of sales is exclusive of amortization, shown
separately.
|
(2)
|
Include
a one-time income tax expense of $1.5 million as a result of changes in
Canadian federal enacted tax rates and an income tax recovery of $2.7
million as a result of changes of our tax strategy, for the three and the
six months ended February 29,
2008.
|
Three
months
ended
February
29,
2008
|
Six
months
ended
February
29,
2008
|
Three
months
ended
February
28,
2007
|
Six
months
ended
February
28,
2007
|
|||||||||||||
(unaudited)
|
(unaudited)
|
|||||||||||||||
Income
tax provision at combined Canadian federal and provincial statutory tax
rate
|
$ | 1,606,000 | $ | 1,980,000 | $ | 1,132,000 | $ | 2,512,000 | ||||||||
Increase
(decrease) due to:
|
||||||||||||||||
Income
taxed at different rates
|
(11,000 | ) | 77,000 | (26,000 | ) | 33,000 | ||||||||||
Non-taxable
income
|
(290,000 | ) | (371,000 | ) | (36,000 | ) | (95,000 | ) | ||||||||
Non-deductible
expenses
|
368,000 | 590,000 | 192,000 | 446,000 | ||||||||||||
Change
in tax rates (1)
|
1,524,000 | 1,522,000 | 18,000 | 289,000 | ||||||||||||
Change
in tax strategy (2)
|
(2,715,000 | ) | (2,715,000 | ) | – | – | ||||||||||
Foreign
exchange effect of translation of foreign integrated
subsidiaries
|
67,000 | 194,000 | 6,000 | 86,000 | ||||||||||||
Other
|
232,000 | 391,000 | 163,000 | 40,000 | ||||||||||||
Utilization
of previously unrecognized future income tax assets
|
(1,881,000 | ) | (1,881,000 | ) | (660,000 | ) | (1,999,000 | ) | ||||||||
Unrecognized
future income tax assets on temporary deductible differences and unused
tax losses and deductions
|
2,095,000 | 2,470,000 | 65,000 | 323,000 | ||||||||||||
Income
tax provision
|
$ | 995,000 | $ | 2,257,000 | $ | 854,000 | $ | 1,635,000 |
(1)
|
During
the three months ended February 29, 2008, reductions to the Canadian
federal statutory tax rate, previously announced by the Canadian federal
Government were enacted. Therefore, Canadian federal future income tax
assets decreased by $1.5 million, and generated a future income tax
expense for the same amount during the three- and six-month periods ended
February 29, 2008.
|
(2)
|
During
the three months ended February 29, 2008, based on new Canadian federal
enacted tax rates, we reviewed our tax strategy for the future use of our
Canadian federal operating losses, research and development expenses,
certain timing differences and research and development tax credits to
minimize income taxes payable on future years’ taxable income, by amending
our prior year’s income tax returns to generate a net operating loss to be
carried back to prior years, which will release previously used research
and development tax credits. This resulted in an increase of our tax
related assets of $2.7 million and in an income tax recovery for the
same amount in the statements of earnings for the three- and six-month
periods ended
February 29, 2008.
|
Expiry
dates
|
Contractual
amounts
|
Weighted
average contractual forward rates
|
||
March
to August 2008
|
$18,100,000
|
1.1184
|
||
September
2008 to December 2009
|
$21,400,000
|
1.0961
|
Stock
Options
|
Number
|
%
of issued and outstanding
|
Weighted
average exercise price
|
|||
Chairman
of the Board, President and CEO (one
individual)
|
179,642
|
10%
|
$9.05
|
|||
Board
of Directors (five individuals)
|
194,375
|
10%
|
$6.23
|
|||
Management
and Corporate Officers (eight
individuals)
|
212,139
|
11%
|
$14.49
|
|||
586,156
|
31%
|
$10.08
|
Restricted
Share Units (RSUs)
|
Number
|
%
of issued and outstanding
|
||||
Chairman
of the Board, President and CEO (one
individual)
|
85,460
|
14%
|
||||
Management
and Corporate Officers (ten
individuals)
|
265,176
|
42%
|
||||
350,636
|
56%
|
Deferred
Share Units (DSUs)
|
Number
|
%
of issued and outstanding
|
||||
Board
of Directors (five individuals)
|
85,797
|
100%
|
Q2-FY08
|
Q1-FY08
|
Q4-FY07
|
Q3-FY07
|
|||||||||||||
Sales
|
$ | 43,281 | $ | 40,985 | $ | 42,975 | $ | 39,205 | ||||||||
Cost
of sales
|
$ | 18,060 | $ | 18,144 | $ | 18,109 | $ | 16,828 | ||||||||
Gross
margin
|
$ | 25,221 | $ | 22,841 | $ | 24,866 | $ | 22,377 | ||||||||
Earnings
from operations
|
$ | 3,635 | $ | 302 | $ | 9,102 | $ | 2,840 | ||||||||
Net
earnings (loss)
|
$ | 4,024 | $ | (93 | ) | $ | 33,484 | $ | 2,574 | |||||||
Basic
net earnings (loss) per share
|
$ | 0.06 | $ | (0.00 | ) | $ | 0.49 | $ | 0.04 | |||||||
Diluted
net earnings (loss) per share
|
$ | 0.06 | $ | (0.00 | ) | $ | 0.48 | $ | 0.04 |
Q2-FY07
|
Q1-FY07
|
Q4-FY06
|
Q3-FY06
|
|||||||||||||
Sales
|
$ | 35,207 | $ | 35,547 | $ | 35,733 | $ | 35,410 | ||||||||
Cost
of sales
|
$ | 14,970 | $ | 15,229 | $ | 16,318 | $ | 15,453 | ||||||||
Gross
margin
|
$ | 20,237 | $ | 20,318 | $ | 19,415 | $ | 19,957 | ||||||||
Earnings
from operations
|
$ | 2,081 | $ | 2,759 | $ | 2,363 | $ | 3,608 | ||||||||
Net
earnings
|
$ | 2,684 | $ | 3,533 | $ | 2,910 | $ | 3,504 | ||||||||
Basic
and diluted net earnings per share
|
$ | 0.04 | $ | 0.05 | $ | 0.04 | $ | 0.05 |